Not applicable Not applicable
Conditions
Interventions
Not applicable
Sponsors
Shindo Shizuo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participation in the study participants who have obtained the voluntary written consent from the father, mother, grandfather, or grandmother of the study subjects and who satisfy the following inclusion criteria and do not violate the exclusion criteria are eligible. Inclusion criteria 1) those who have been enrolled in the J301 trial and received the clinical trial vaccine 2) those who have been judged by the principal investigator or co-investigator to have no problems participating in this study
Exclusion criteria
Exclusion criteria: 1) those who have received an additional dose of combined measles-rubella vaccine (MR vaccine) or mumps vaccine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) The incidence of measles, rubella, and mumps from the time of the clinical trial vaccination until the start of this study 2) Antibody titers against measles virus, rubella virus, and mumps virus at the start of this study | — |
Contacts
Public ContactShizuo Shindo
shindo children's clinic
Outcome results
None listed